Istiratumab Uses, Dosage, Side Effects and more
Istiratumab is under investigation in clinical trial NCT02399137 (A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Istiratumab |
| Generic | Istiratumab |
| Istiratumab Other Names | Istiratumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
